TLI Investigator Dr. Lynda Polgreen’s Study Published in Nature Medicine Showing Promising New Treatment for Sanfilippo Syndrome

Dr. Polgreen
Investigator(s): Lynda Polgreen, MD, MS

The groundbreaking study was led by Lynda Polgreen, MD, MS,  Investigator at The Lundquist Institute for Biomedical Innovation (TLI) and Associate Professor of Pediatrics at the David Geffen School of Medicine at UCLA, focused on using anakinra, a recombinant interleukin-1 receptor antagonist, on addressing the neuroinflammation component of Sanfilippo Syndrome.

Read more

TLI Investigator Dr. Marianne Gausche-Hill Co-authors New Study Revealing Cost-Effectiveness of Pediatric Readiness in Emergency Departments

Marianne Gausche-Hill, MD, FACEP, FAAP, FAEMS
Investigator(s): Marianne Gausche-Hill, MD, FACEP, FAAP, FAEMS

Becoming highly pediatric-ready could decrease child mortality rates by up to 76%

Read more

A Trailblazer Returns: 94-Year-Old Mary Burns Revisits Lundquist Institute for Groundbreaking COPD Study

Mary Burns with Dr. Casaburi
Investigator(s): Richard Casaburi, PhD, MD

Marking a special milestone for medical research, Mary Burns, a 94-year-old trailblazer in the battle against chronic obstructive pulmonary disease (COPD), made her return to The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI). Fifteen years ago, Burns was the first to join the COPDGene study — a cutting-edge investigation seeking to unravel the complexities of COPD. As she walked through the doors of the Respiratory Research Center, it was more than just a routine check-up; it marked the inauguration of "Phase 4" of this pivotal study.

Read more